Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial
- Thursday, May 12, 2022, 7:14
- Environment
- Add a comment
WIXOM, Mich., May 12, 2022 /PRNewswire/ — Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that it provided the U.S. Food and Drug Administration (FDA) with the…
About the Author
adminasapcorp has written 41562 stories on this site.